Advisory Services Network’s Tvardi Therapeutics TVRD Stock Holding History

Advisory Services Network’s Portfolio TVRD Stock Details TVRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-28	Closed	-$15K	–	3013
2020 Q4	$15K	Sell	28 -83	-75%	-$43.5K	﹤0.01%	2263
2020 Q3	$51K	Buy	+111	New	+$64.5K	﹤0.01%	1584
2020 Q2	–	Sell	-28	Closed	-$14K	–	2812
2020 Q1	$14K	Hold	28	–	–	﹤0.01%	2089
2019 Q4	$16K	Sell	28 -220	-89%	-$154K	﹤0.01%	2142
2019 Q3	$192K	Hold	248	–	–	0.01%	843
2019 Q2	$192K	Hold	248	–	–	0.01%	841
2019 Q1	$175K	Buy	248 +9	+4%	+$5.39K	0.01%	819
2018 Q4	$112K	Buy	239 +238	+23,800%	+$154K	0.01%	867
2018 Q3	$1K	Buy	+1	New	+$722	﹤0.01%	2453

Other funds holding TVRD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCP

Rho Capital Partners New York $20.4M AUM

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Advisory Services Network's TVRD Position: Q1 2021 in Review

Advisory Services Network sold out of Tvardi Therapeutics (TVRD) in Q1 2021, closing a stake of 28 shares — an estimated $15K sold.

Advisory Services Network first reported a position in TVRD in Q3 2018 and held it in 9 quarters. The position peaked at $192K in Q3 2019. 167 funds tracked by Wall St. Rank hold TVRD as of Q1 2021.

Advisory Services Network reported no remaining Tvardi Therapeutics position as of Q1 2021 after selling out during the quarter.
Advisory Services Network sold 28 Tvardi Therapeutics shares in Q1 2021, an estimated $15K.
Advisory Services Network first reported a position in Tvardi Therapeutics in Q3 2018 and held it in 9 quarters.
Advisory Services Network's Tvardi Therapeutics position peaked at $192K in Q3 2019.
167 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q1 2021.

Based on Advisory Services Network's 13F filing for Q1 2021, filed 24 May 2021.